# Ciprofloxacin

NDC: 58657-675
Generic name: Ciprofloxacin
Labeler / Manufacturer: Method Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20200812

FDA application: ANDA208921

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58657-675"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58657-675
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acb03e72-ce94-58c5-e053-2a95a90a683a